Since exposure to high doses of rotenone (100 nM) disrupt proteasome activity and increase ROS synthesis (Chou et al., 2010), and rotenone exposure also induce Tau hyperphosphorylation, it is plausible postulate that rotenone reproduce some early aspects related with AD pathophysiology. This evidence concerns the gene MAPT and Alzheimer disease.